January 22, 2021 07:09 AM ESTUpdated 09:52 AM
Coronavirus

Covid-19 roundup: Eu­rope to seek clar­i­fi­ca­tion on Pfiz­er/BioN­Tech de­lays; J&J pre­dicts 100M dos­es for US by April

Max Gelman

Senior Editor

With re­ports over slowed dis­tri­b­u­tion of the Pfiz­er/BioN­Tech vac­cine and threats of law­suits dan­gling, the Eu­ro­pean Com­mis­sion is plan­ning to ask the com­pa­ny for a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times